Code 1 Wellness | |
302 S Main St # 258 Archie MO 64725-9608 | |
(816) 372-2948 | |
Not Available |
Full Name | Code 1 Wellness |
---|---|
Speciality | Social Worker - Clinical |
Location | 302 S Main St # 258, Archie, Missouri |
Authorized Official Name and Position | Vanessa Kennedy (CEO) |
Authorized Official Contact | 8163722948 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Code 1 Wellness 302 S Main St # 258 Archie MO 64725-9608 Ph: (816) 372-2948 | Code 1 Wellness 302 S Main St # 258 Archie MO 64725-9608 Ph: (816) 372-2948 |
NPI Number | 1407475486 |
---|---|
Provider Enumeration Date | 04/10/2020 |
Last Update Date | 01/04/2023 |
Certification Date | 01/04/2023 |
Identifier | Type | State | Issuer |
---|---|---|---|
1407475486 | NPI | - | NPPES |
News Archive
Health conscious consumers who hesitate at the price of fresh blueberries and blackberries, fruits renowned for high levels of healthful antioxidants, now have an economical alternative, scientists reported here today at the 240th National Meeting of the American Chemical Society. It is black rice, one variety of which got the moniker "Forbidden Rice" in ancient China because nobles commandeered every grain for themselves and forbade the common people from eating it.
The ability to distinguish between different kinds of caresses on the skin already exists at a very early age. This is evident from a study by the Sahlgrenska Academy, in which the blood supply in brains of infants 6 to 10 weeks old was investigated.
A new study led by a research team at Leicester's Hospitals hope to reveal, using magnetic resonance imaging (MRI), why young people with Type-2 diabetes develop heart damage.
Severe Combined Immunodeficiency occurs in just one out of every 50,000 to 100,000 births in the United States, yet it is the most serious primary immunodeficiency disorder. A study published today in Blood, the Journal of the American Society of Hematology, demonstrates that babies with SCID who are diagnosed at birth and receive a hematopoietic stem cell transplant, which is the transplantation of blood-forming stem cells, have significantly improved survival.
Data presented today at the European Society of Cardiology Congress demonstrates the effectiveness of a peptide called FX06 in preventing cardiac damage resulting from treatment following a heart attack.
› Verified 4 days ago